FDA counters KV s premature warning against compounding early-labor prevention drug

By ACSH Staff — Mar 31, 2011
KV pharmaceuticals recently won exclusive rights to the marketing of the pre-term labor prevention drug they’ve branded Makena. Priced at a whopping $1500 per shot, the therapy may cost up to $30,000 per pregnancy since it usually requires 20 weekly injections to prevent premature labor in patients who have a predisposition to or a history of going into premature labor.

KV pharmaceuticals recently won exclusive rights to the marketing of the pre-term labor prevention drug they’ve branded Makena. Priced at a whopping $1500 per shot, the therapy may cost up to $30,000 per pregnancy since it usually requires 20 weekly injections to prevent premature labor in patients who have a predisposition to or a history of going into premature labor.

Study lauds BPA- and DEHP-free diet: But where s the harm?

By ACSH Staff — Mar 31, 2011
If it were up to The Silent Spring Institute and the Breast Cancer Fund, both activist groups disguised as environmental and health advocacy organizations, they would have you believe that the results of their newest study, with funding from the Passport Foundation, justify the need to convert to a non-packaged, organic food (and maybe raw?) diet.

If it were up to The Silent Spring Institute and the Breast Cancer Fund, both activist groups disguised as environmental and health advocacy organizations, they would have you believe that the results of their newest study, with funding from the Passport Foundation, justify the need to convert to a non-packaged, organic food (and maybe raw?) diet.

Surprise: FDA tells Star Scientific its dissolvable tobacco lozenge not regulated under tobacco law

By ACSH Staff — Mar 30, 2011
In a surprise ruling, the FDA determined last week that tobacco product maker Star Scientific Inc. is free to market and sell its Ariva-BDL and Stonewall-BDL dissolvable tobacco lozenges independent of FDA regulation since the products do not fall under the jurisdiction of the 2009 Family Smoking Prevention and Tobacco Control Act.

In a surprise ruling, the FDA determined last week that tobacco product maker Star Scientific Inc. is free to market and sell its Ariva-BDL and Stonewall-BDL dissolvable tobacco lozenges independent of FDA regulation since the products do not fall under the jurisdiction of the 2009 Family Smoking Prevention and Tobacco Control Act.

Biodiversity doesn t feed people, but GM crops do

By ACSH Staff — Mar 30, 2011
During a United Nations meeting in Bali to discuss a treaty on plant genetics, La Via Campesina, which according to an article in The Atlantic, is said to be an international farmers movement comprised of 150 organizations in 70 countries, decided not to waste time addressing real agricultural problems like the rising cost of food, starvation in underdeveloped nations and the poor crop yields in certain areas.

During a United Nations meeting in Bali to discuss a treaty on plant genetics, La Via Campesina, which according to an article in The Atlantic, is said to be an international farmers movement comprised of 150 organizations in 70 countries, decided not to waste time addressing real agricultural problems like the rising cost of food, starvation in underdeveloped nations and the poor crop yields in certain areas.

Elderly excluded from many drug trials for treatments aimed at them

By ACSH Staff — Mar 30, 2011
A new study in the Archives of Internal Medicine shows that 43 percent of 251 clinical trials investigating heart failure show evidence of ageism. According to lead author Dr.

A new study in the Archives of Internal Medicine shows that 43 percent of 251 clinical trials investigating heart failure show evidence of ageism. According to lead author Dr.

The X-Ray(t)ed Truth: Airport scanners pose no health threat

By ACSH Staff — Mar 30, 2011
After the Transportation Security Administration announced the installation of new body scanners in airports last year, the mass media ran amok, hyping up the public’s fears of excess radiation exposure and privacy violations.

After the Transportation Security Administration announced the installation of new body scanners in airports last year, the mass media ran amok, hyping up the public’s fears of excess radiation exposure and privacy violations.

CSPI dyeing to link food coloring to ADHD

By ACSH Staff — Mar 29, 2011
Like the mole in the whack-a-mole game, the Center for Science in the Public Interest’s Michael Jacobson just keeps coming back for a good whack in the head. This time, he has tried to resurrect the unfounded claim that food dyes trigger Attention Deficit Hyperactivity Disorder (ADHD) in kids who are predisposed to it — an issue first introduced in the 1970s by Dr. Ben Feingold.

Like the mole in the whack-a-mole game, the Center for Science in the Public Interest’s Michael Jacobson just keeps coming back for a good whack in the head. This time, he has tried to resurrect the unfounded claim that food dyes trigger Attention Deficit Hyperactivity Disorder (ADHD) in kids who are predisposed to it — an issue first introduced in the 1970s by Dr. Ben Feingold.

The EPA: More trouble than it s worth and should be abolished, says Dr. Miller

By ACSH Staff — Mar 29, 2011
Happy 40th Birthday, EPA, and may it be the last, says Hoover Institution Fellow and former ACSH trustee Dr. Henry Miller. In yet another Regulation article, Dr. Miller counters EPA Administrator Lisa Jackson’s op-ed in The Wall Street Journal, in which she defends the agency’s environmental “health” mission and asks for a birthday gift of continued funding. Dr. Miller writes:

Happy 40th Birthday, EPA, and may it be the last, says Hoover Institution Fellow and former ACSH trustee Dr. Henry Miller. In yet another Regulation article, Dr. Miller counters EPA Administrator Lisa Jackson’s op-ed in The Wall Street Journal, in which she defends the agency’s environmental “health” mission and asks for a birthday gift of continued funding. Dr. Miller writes:

In defense of vaccines

By ACSH Staff — Mar 29, 2011
ACSH staffers were pleased to encounter a variety of pieces defending vaccines as a vital public health practice. A book review in today’s The New York Times, for instance, features an excellent work by informed consumer and Vanity Fair Contributing Editor Seth Mnookin. The Times’ Dr.

ACSH staffers were pleased to encounter a variety of pieces defending vaccines as a vital public health practice. A book review in today’s The New York Times, for instance, features an excellent work by informed consumer and Vanity Fair Contributing Editor Seth Mnookin. The Times’ Dr.